Market Overview:
The global image-guided therapy systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer and other diseases, rising demand for minimally invasive surgeries, and technological advancements in image-guided therapy systems. Based on type, the global image-guided therapy systems market is segmented into computed tomography (CT) scanners, ultrasound systems, magnetic resonance imaging (MRI), endoscope, x-ray fluoroscopy, positron emission tomography (PET), and single photon emission computed tomography (SPECT). CT scanners held the largest share of the global image-guided therapy systems market in 2017. This segment is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for CT scans for diagnosis and treatment purposes. Based on application, the global image-guided therapy systems market is segmented into cardiac surgery, neurosurgery,, orthopedic surgery,, urology,, gastroenterology,, oncology surgery,, and others*. Cardiac surgery held the largest share of this market in 2017 owing to rising prevalence of cardiovascular diseases across the globe.
Product Definition:
An image-guided therapy system is a medical device that uses imaging technology to help physicians guide treatments such as surgery, radiation therapy, or chemotherapy. The importance of image-guided therapy systems is that they allow physicians to more accurately target treatments and improve patient outcomes.
Computed Tomography (CT) Scanners:
Computed tomography scanners (CT) are medical devices that diagnose and treat diseases by producing cross-sectional images of targeted areas of the body. CT scanners work on the principle of X-rays; they produce multiple small X-ray beams instead of a single large beam used in conventional x-ray machines. These smaller beams allow for more accurate and detailed imaging, which is expected to drive market growth over the forecast period.
Ultrasound Systems:
Ultrasound systems are medical devices that produce and apply ultrasound energy to tissues for the treatment of disease. It is a non-invasive technique, which helps in treating cancerous cells and can also be used for cosmetic purposes. The ultrasonic nebulizer uses high frequency sound waves to break up unwanted substances like tissue, blood cells, etc., into small pieces thus making it an effective method of destroying malignant tumors.
Application Insights:
The others segment dominated the global image-guided therapy systems market in 2017 and is expected to grow at a lucrative CAGR during the forecast period. This can be attributed to growing adoption of these systems for treatment of various diseases, such as cancer, liver disorders, kidney disorders, digestive system disorders and cardiovascular diseases.
Cardiac surgery accounted for a significant share in 2017 owing to rising incidence of heart-related diseases across all age groups. According to WHO¢â‚¬â„¢s statistics published in 2018, out of which around 1 in 3 deaths occur due to Cardiovascular Diseases (CVDs) globally. Moreover, increasing number of cardiac surgeries being performed worldwide is further driving growth.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing prevalence of target diseases. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Europe accounted for a significant share in global market due to growing geriatric population base and rising incidences of cancer & other diseases.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to untapped opportunities in this region along with developing healthcare infrastructure & facilities especially in China & India which accounts for majority share by country.
Growth Factors:
- Increasing incidence of cancer and other chronic diseases: The global incidence of cancer is increasing at an alarming rate. According to the World Health Organization (WHO), the number of new cases is expected to rise from 14 million in 2012 to 22 million by 2030. This will create a large demand for image-guided therapy systems, which can help in accurate diagnosis and treatment of cancers and other chronic diseases.
- Growing demand for minimally invasive procedures: Minimally invasive procedures are becoming increasingly popular due to their many benefits over traditional surgery, such as shorter hospital stays, reduced pain, and faster recovery times. Image-guided therapy systems allow surgeons to perform these procedures with greater accuracy and precision, resulting in better patient outcomes.
- Advances in technology: The field of image-guided therapy is constantly evolving with new advances in technology that improve the accuracy and precision of diagnosis and treatment planning. This is helping to drive growth in the market as hospitals invest in newer systems that offer improved performance over older models.
Scope Of The Report
Report Attributes
Report Details
Report Title
Image-guided Therapy Systems Market Research Report
By Type
Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscope, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT)
By Application
Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery, Others
By Companies
Philips Healthcare, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Image-guided Therapy Systems Market Report Segments:
The global Image-guided Therapy Systems market is segmented on the basis of:
Types
Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscope, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips Healthcare
- Siemens Healthineers
- GE Healthcare
- Fujifilm Holdings Corporation
- ...
Highlights of The Image-guided Therapy Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Computed Tomography (CT) Scanners
- Ultrasound Systems
- Magnetic Resonance Imaging (MRI)
- Endoscope
- X-ray Fluoroscopy
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- By Application:
- Cardiac Surgery
- Neurosurgery
- Orthopedic Surgery
- Urology
- Gastroenterology
- Oncology Surgery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Image-guided Therapy Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Image-guided therapy systems are devices that use images from a patient's medical record to provide guidance to healthcare professionals during treatment. Images can be used to help identify abnormalities, plan treatments, and monitor patients.
Some of the major players in the image-guided therapy systems market are Philips Healthcare, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation.
The image-guided therapy systems market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Image-guided Therapy Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Image-guided Therapy Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Image-guided Therapy Systems Market - Supply Chain
4.5. Global Image-guided Therapy Systems Market Forecast
4.5.1. Image-guided Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Image-guided Therapy Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Image-guided Therapy Systems Market Absolute $ Opportunity
5. Global Image-guided Therapy Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Image-guided Therapy Systems Market Size and Volume Forecast by Type
5.3.1. Computed Tomography (CT) Scanners
5.3.2. Ultrasound Systems
5.3.3. Magnetic Resonance Imaging (MRI)
5.3.4. Endoscope
5.3.5. X-ray Fluoroscopy
5.3.6. Positron Emission Tomography (PET)
5.3.7. Single Photon Emission Computed Tomography (SPECT)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Image-guided Therapy Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Image-guided Therapy Systems Market Size and Volume Forecast by Application
6.3.1. Cardiac Surgery
6.3.2. Neurosurgery
6.3.3. Orthopedic Surgery
6.3.4. Urology
6.3.5. Gastroenterology
6.3.6. Oncology Surgery
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Image-guided Therapy Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Image-guided Therapy Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Image-guided Therapy Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Image-guided Therapy Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Image-guided Therapy Systems Demand Share Forecast, 2019-2029
9. North America Image-guided Therapy Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Image-guided Therapy Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Image-guided Therapy Systems Market Size and Volume Forecast by Application
9.4.1. Cardiac Surgery
9.4.2. Neurosurgery
9.4.3. Orthopedic Surgery
9.4.4. Urology
9.4.5. Gastroenterology
9.4.6. Oncology Surgery
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Image-guided Therapy Systems Market Size and Volume Forecast by Type
9.7.1. Computed Tomography (CT) Scanners
9.7.2. Ultrasound Systems
9.7.3. Magnetic Resonance Imaging (MRI)
9.7.4. Endoscope
9.7.5. X-ray Fluoroscopy
9.7.6. Positron Emission Tomography (PET)
9.7.7. Single Photon Emission Computed Tomography (SPECT)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Image-guided Therapy Systems Demand Share Forecast, 2019-2029
10. Latin America Image-guided Therapy Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Image-guided Therapy Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Image-guided Therapy Systems Market Size and Volume Forecast by Application
10.4.1. Cardiac Surgery
10.4.2. Neurosurgery
10.4.3. Orthopedic Surgery
10.4.4. Urology
10.4.5. Gastroenterology
10.4.6. Oncology Surgery
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Image-guided Therapy Systems Market Size and Volume Forecast by Type
10.7.1. Computed Tomography (CT) Scanners
10.7.2. Ultrasound Systems
10.7.3. Magnetic Resonance Imaging (MRI)
10.7.4. Endoscope
10.7.5. X-ray Fluoroscopy
10.7.6. Positron Emission Tomography (PET)
10.7.7. Single Photon Emission Computed Tomography (SPECT)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Image-guided Therapy Systems Demand Share Forecast, 2019-2029
11. Europe Image-guided Therapy Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Image-guided Therapy Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Image-guided Therapy Systems Market Size and Volume Forecast by Application
11.4.1. Cardiac Surgery
11.4.2. Neurosurgery
11.4.3. Orthopedic Surgery
11.4.4. Urology
11.4.5. Gastroenterology
11.4.6. Oncology Surgery
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Image-guided Therapy Systems Market Size and Volume Forecast b Type
11.7.1. Computed Tomography (CT) Scanners
11.7.2. Ultrasound Systems
11.7.3. Magnetic Resonance Imaging (MRI)
11.7.4. Endoscope
11.7.5. X-ray Fluoroscopy
11.7.6. Positron Emission Tomography (PET)
11.7.7. Single Photon Emission Computed Tomography (SPECT)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Image-guided Therapy Systems Demand Share, 2019-2029
12. Asia Pacific Image-guided Therapy Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Image-guided Therapy Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Image-guided Therapy Systems Market Size and Volume Forecast by Application
12.4.1. Cardiac Surgery
12.4.2. Neurosurgery
12.4.3. Orthopedic Surgery
12.4.4. Urology
12.4.5. Gastroenterology
12.4.6. Oncology Surgery
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Image-guided Therapy Systems Market Size and Volume Forecast by Type
12.7.1. Computed Tomography (CT) Scanners
12.7.2. Ultrasound Systems
12.7.3. Magnetic Resonance Imaging (MRI)
12.7.4. Endoscope
12.7.5. X-ray Fluoroscopy
12.7.6. Positron Emission Tomography (PET)
12.7.7. Single Photon Emission Computed Tomography (SPECT)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Image-guided Therapy Systems Demand Share, 2019-2029
13. Middle East & Africa Image-guided Therapy Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Image-guided Therapy Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Image-guided Therapy Systems Market Size and Volume Forecast by Application
13.4.1. Cardiac Surgery
13.4.2. Neurosurgery
13.4.3. Orthopedic Surgery
13.4.4. Urology
13.4.5. Gastroenterology
13.4.6. Oncology Surgery
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Image-guided Therapy Systems Market Size and Volume Forecast by Type
13.7.1. Computed Tomography (CT) Scanners
13.7.2. Ultrasound Systems
13.7.3. Magnetic Resonance Imaging (MRI)
13.7.4. Endoscope
13.7.5. X-ray Fluoroscopy
13.7.6. Positron Emission Tomography (PET)
13.7.7. Single Photon Emission Computed Tomography (SPECT)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Image-guided Therapy Systems Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Image-guided Therapy Systems Market: Market Share Analysis
14.2. Image-guided Therapy Systems Distributors and Customers
14.3. Image-guided Therapy Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Philips Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens Healthineers
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GE Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fujifilm Holdings Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ...
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Ove
